Australia's most trusted
source of pharma news
Friday, 20 September 2024
Friday, 20 September 2024
Subscribe
Login
News Headlines
News Headlines
Listen to this story
News
Cloud hangs over drug's future
Posted 17 September 2024 AM
The future of Ocaliva could be in jeopardy with regulators overseas calling into question the effectiveness and safety of the primary biliary cholangitis (PBC) treatment.
Ocaliva, marketed in Australia by Chiesi, was granted full approval in 2018 for the treatment of PBC in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA.
To see the whole article, please login
Posted 17 September 2024 AM
The future of Ocaliva could be in jeopardy with regulators overseas calling into question the effectiveness and safety of the primary biliary cholangitis (PBC) treatment.
Ocaliva, marketed in Australia by Chiesi, was granted full approval in 2018 for the treatment of PBC in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (5)
- Manufacturing Data Analyst - Blacktown
- Brand Manager - Sydney
- Senior Brand Manager - Sydney
- Brand Manager - Sydney
- Senior Brand Manager - Sydney
Sales & Customer Relations (21)
- Territory Manager - Capital Equipment - Melbourne
- GP Sales Representative - Brisbane
- Medical Sales Representative - New South Wales
- Customer Service Representative - Mount Waverley
- Hospital Specialist Representative - Sydney
- Customer Service Representative - Sydney
- Customer Service Representative - Toongabbie
- Customer Service Representative - Frenchs Forest
- Salesforce Developer - Sydney
- GP Sales Representative - Women's Health - NSW North - Sydney
- Hospital Specialist Representative - Brisbane
- Customer Support Representative - Western Australia
- GP Sales Representative - Women's Health - NSW North - Sydney
- Hospital Sales Representative - New South Wales
- Specialist Sales Representative - Melbourne
- Hospital Sales Representative - New South Wales
- Hybrid Pharmaceutical Sales Representative - Brisbane
- Territory Manager - Melbourne
- GP Sales Representative - Sydney
- Account Manager - Melbourne
- Customer Care Representative - Blackburn
Clinical & Medical, R&D (12)
- Medical Affairs Associate - Sydney
- Medical Sales Representative - New South Wales
- Senior Clinical Research Scientist - Sydney
- Medical Recruitment Consultant - Sydney
- Medical Science Liaison - Oncology - QLD - Brisbane
- Medical Science Liaison - Ophthalmology - Queensland
- Medical Science Liaison - Ophthalmology - Sydney
- Medical Science Liaison - Ophthalmology - Melbourne
- Associate Scientist - Melbourne
- Clinical Trial Network Site Partner - Sydney
- Medical Affairs Manager - APAC - Sydney
- Senior Specialist, Site Inspections and Compliance - Parkville
Regulatory, Pharmacovigilance & QA (6)
- RA/QA Specialist - Sydney
- Quality Control Virology Analyst - Parkville
- Regulatory Affairs Manager - Sydney
- Quality Assurance Associate - Tullamarine
- Senior Consultant - Regulatory, Quality & Compliance - Australia
- Director, Operations Quality - Macquarie Park
Other (10)
- Warehouse Assistant - North Ryde
- Warehouse Assistant - North Ryde
- MSL - Oncology/Haematology - QLD - Brisbane
- EHS Advisor - Blacktown
- Sterility Assurance Specialist - Dallas
- Drug Safety Controller - Melbourne
- Storeperson - Macquarie Park
- WHS Advisor - Macquarie Park
- Senior Commercial Insights Analyst - Sydney, NSW
- Recruitment Consultant - Sydney
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.